- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Refractory Tumors in United Kingdom
Total 10746 results
-
AstraZenecaParexelTerminatedAdvanced Solid TumoursUnited Kingdom, United States
-
Hoffmann-La RocheCompletedSolid TumorUnited Kingdom, Netherlands
-
AmgenCompletedCancer | Giant Cell Tumor of Bone | Giant Cell Tumors | Benign Giant Cell TumorsUnited States, Canada, Sweden, Poland, Germany, Netherlands, Australia, Italy, Austria, Spain, France, United Kingdom
-
Bristol-Myers SquibbCompletedAdvanced MelanomaUnited States, United Kingdom
-
Scancell LtdTerminated
-
Bristol-Myers SquibbTerminatedAdvanced Solid TumorsUnited States, Canada, United Kingdom
-
University of Wisconsin, MadisonNot yet recruitingNeuroendocrine Tumors | Somatostatin Receptor-positive Neuroendocrine TumorUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedBrain and Central Nervous System Tumors | NeuroblastomaUnited States
-
Novartis PharmaceuticalsCompletedAdvanced Solid TumorsSwitzerland, Netherlands, United States, United Kingdom
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal TumorUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedEwing Sarcoma of Bone | Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal TumorUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingRecurrent Neuroblastoma | Refractory Neuroblastoma | High Risk NeuroblastomaUnited States, Canada, Puerto Rico, Australia, New Zealand
-
Innervate Radiopharmaceuticals LLC (Formerly: Illumina...Albert Einstein College of MedicineNot yet recruitingNeuroblastoma | Pheochromocytoma | ParagangliomaUnited States
-
Herbert Irving Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
-
David BushnellNational Cancer Institute (NCI); National Institutes of Health (NIH); Progenics...WithdrawnNeuroendocrine Tumors | Gastro-enteropancreatic Neuroendocrine TumorUnited States
-
East and North Hertfordshire NHS TrustKing's College LondonRecruitingMelanoma (Skin)United Kingdom
-
Case Comprehensive Cancer CenterCompletedMyelodysplastic Syndromes | Thrombocytopenia | Chronic Myelomonocytic Leukemia | de Novo Myelodysplastic Syndromes | Refractory Anemia | Refractory Anemia With Excess Blasts | Refractory Cytopenia With Multilineage Dysplasia | Refractory Anemia With Ringed SideroblastsUnited States
-
GlaxoSmithKlineCompletedSolid Tumor CancerUnited Kingdom
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal TumorUnited States
-
Advanced Accelerator ApplicationsActive, not recruitingPheochromocytoma | Paraganglioma | Gastroenteropancreatic Neuroendocrine TumorsUnited States, Spain, France, Poland, United Kingdom
-
Daiichi Sankyo, Inc.OptimapharmCompletedGiant Cell TumorsUnited States, France, Spain, Netherlands, Italy, Austria, United Kingdom, Germany
-
AstraZenecaCompletedGastrointestinal Stromal Tumors | Soft Tissue SarcomasUnited Kingdom
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Solid Tumors | Relapsed/Refractory LymphomaUnited States
-
National Cancer Institute (NCI)RecruitingRecurrent WHO Grade 2 Glioma | Recurrent Low Grade Astrocytoma | Refractory Low Grade Astrocytoma | Refractory Low Grade Glioma | Refractory WHO Grade 1 GliomaUnited States, Canada
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedBrain Tumor | Central Nervous System TumorUnited States, Canada, Australia, Puerto Rico
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Solid Tumors | Relapsed/Refractory LymphomaUnited States
-
Medical Research CouncilCompletedTesticular Germ Cell TumorUnited Kingdom
-
National Cancer Institute (NCI)Active, not recruitingMalignant Glioma | Rhabdoid Tumor | Advanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Recurrent Ependymoma | Recurrent Ewing Sarcoma | Recurrent Hepatoblastoma | Recurrent Langerhans Cell Histiocytosis | Recurrent Malignant Germ Cell Tumor | Recurrent Malignant Solid Neoplasm | Recurrent... and other conditionsUnited States, Puerto Rico
-
Cancer Research UKCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited Kingdom
-
Nova Laboratories LimitedCompleted
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation Trust; Nottingham University Hospitals NHS Trust; Barts & The London NHS Trust and other collaboratorsRecruitingHormone Refractory Prostate CancerUnited Kingdom
-
Children's Hospital Medical Center, CincinnatiActive, not recruitingAdult Solid Tumor | Relapsed Cancer | Refractory Cancer | Childhood Solid Tumor | Childhood Lymphoma | Adult LymphomaUnited States
-
Stemline Therapeutics, Inc.CompletedStudy of the PI3K Inhibitor SL-901 in Patients With Advanced Solid Tumors With Advanced Solid TumorsAdvanced Solid TumorUnited Kingdom
-
Dana-Farber Cancer InstituteBristol-Myers Squibb; ExelixisCompletedNeuroendocrine Tumors | Carcinoid Tumor | Carcinoid Tumor of GI SystemUnited States
-
University of LeicesterUniversity of Nottingham; Nottingham University Hospitals NHS TrustCompleted
-
Heidelberg Pharma AGTerminatedAdvanced Solid TumoursUnited Kingdom
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)CompletedSarcoma | Kidney Cancer | Unspecified Childhood Solid Tumor, Protocol Specific | Ovarian Cancer | Brain and Central Nervous System Tumors | Neuroblastoma | Liver Cancer | Extragonadal Germ Cell Tumor | Childhood Germ Cell TumorUnited States
-
AstraZenecaCompletedBrain Tumor | Recurrent GlioblastomaUnited States, United Kingdom
-
Children's Cancer and Leukaemia GroupUnknownBrain and Central Nervous System TumorsUnited Kingdom, Ireland
-
University of GlasgowCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited Kingdom
-
University of GlasgowCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited Kingdom
-
AstraZenecaCompletedMelanoma | Malignant MelanomaUnited Kingdom, Netherlands
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedBrain Tumor | Central Nervous System TumorUnited States
-
Boston Children's HospitalCompletedAML | ALL | Biphenotypic Leukemia | Refractory Anemia | Refractory Cytopenia With Multilineage Dysplasia | Refractory Anemia With Ringed Sideroblasts | Undifferentiated Leukemia | Ref. Cytopenia w Multilineage Dysplasia & Ringed Sideroblasts | Refractory Anemia With Excess Blasts-1 (5-10% Blasts) | Refractory... and other conditionsUnited States
-
Novartis PharmaceuticalsCompletedSolid TumorsNetherlands, Spain, United Kingdom, United States, Belgium
-
University Hospital, ToursEuropean Academy of Dermatology and VenerologyNot yet recruitingMerkel Cell CarcinomaUnited Kingdom, Austria, Finland, France, Germany, Italy, Netherlands, Romania, Sweden, Turkey
-
National Cancer Institute (NCI)RecruitingRecurrent Malignant Glioma | Recurrent Medulloblastoma | Refractory Malignant Glioma | Refractory Medulloblastoma | Recurrent Diffuse Intrinsic Pontine Glioma | Recurrent Primary Central Nervous System Neoplasm | Refractory Primary Central Nervous System Neoplasm | Refractory Diffuse Intrinsic Pontine...United States, Canada
-
Eisai Inc.Merck Sharp & Dohme LLCCompletedRecurrent and Refractory Solid TumorsUnited States, Canada
-
National Cancer Institute (NCI)CompletedMetastatic Gastrointestinal Carcinoid Tumor | Recurrent Gastrointestinal Carcinoid Tumor | Regional Gastrointestinal Carcinoid TumorUnited States
-
St. Jude Children's Research HospitalRecruitingSolid Tumor | CNS Tumor | ALL, AdultUnited States